CHEK1 and nasopharyngeal carcinoma: Meanwhile, our previous study has also revealed that4 Epstein–Barr virus (EBV) could activate the ATR-CHK1 pathway in nasopharyngeal carcinoma (NPC) cells, and ATR was a key factor in this process.